Release 5 Preview #3

Immunization-example-protocol

Public Health and Emergency Response Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile Immunization.


Generated Narrative

identifier: id: urn:oid:1.3.6.1.4.1.21367.2005.3.7.1234

status: completed

vaccineCode: Twinrix (HepA/HepB)

manufacturer: Generated Summary: name: Health Level Seven International; alias: HL7 International; Phone: (+1) 734-677-7777, Fax: (+1) 734-677-6622, hq@HL7.org

lotNumber: PT123F

expirationDate: 2018-12-15

patient: Generated Summary: Medical record number: 12345 (USUAL); active; Peter James Chalmers (OFFICIAL), Jim , Peter James Windsor (MAIDEN); , Phone: (03) 5555 6473, Phone: (03) 3410 5613, Phone: (03) 5555 8834; gender: male; birthDate: 1974-12-25;

encounter: Generated Summary: status: in-progress; inpatient encounter

occurrence: 2018-06-18

primarySource: true

location: Generated Summary: id: B1-S.F2; status: active; name: South Wing, second floor; alias: BU MC, SW, F2, alias: Burgers University Medical Center, South Wing, second floor; description: Second floor of the Old South Wing, formerly in use by Psychiatry; mode: instance; Phone: 2328, Fax: 2329, second wing admissions, http://sampleorg.com/southwing; Wing

site: left arm

route: Injection, intramuscular

doseQuantity: 5 mg

performer

function: Ordering Provider

actor: Generated Summary: id: 23; active; Adam Careful

performer

function: Administering Provider

actor: Generated Summary: id: 23; active; Adam Careful

isSubpotent: false

programEligibility: Not Eligible

fundingSource: Private

protocolApplied

series: 2-dose

targetDisease: Viral hepatitis, type A

doseNumber: 1

protocolApplied

series: 3-dose

targetDisease: Type B viral hepatitis

doseNumber: 2

seriesDoses: 3


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.